AzTrials
AzTrials

StrokeNCT07691411

An Ecological Momentary Assessment Based Program to Support Self-Management for Post-stroke Patients

A study testing Ecological Momentary Assessment based Self-management Program in people with Stroke and Post Stroke, run by The Hong Kong Polytechnic University at 1 site in Hong Kong.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this feasibility study is to test whether a new approach that combines real-time symptom tracking (Ecological Momentary Assessment) with machine learning can help people recovering from a stroke to better manage depression, thinking difficulties, and daily functioning. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Stroke, Post Stroke
What is being tested?
Ecological Momentary Assessment based Self-management Program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteHong Kong
Study dates
6 Jan 2026to 30 Nov 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • adults aged 18 years or older
  • having a confirmed diagnosis of stroke
  • having sufficient proficiency in Cantonese to understand and respond to the assessments and prompts
  • having a Hong Kong version of the Montreal Cognitive Assessment (HK-MoCA) score of 18 or higher
  • having a smartphone.

Who cannot join

  • they have moderate to severe cognitive impairment (a HK-MoCA score of 17 or lower)
  • they have active psychiatric disorders other than depression (e.g., schizophrenia, bipolar disorder)
  • they have a terminal illness or prognosis that suggests a limited life expectancy
  • they have conditions that compromise their self-care ability (i.e., bedbound).

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Arkers KC Prof. Wong, PhD contact

+852 34003805

arkers.wong@polyu.edu.hk

Hong Kong1 site, 1 recruiting
  • Queen Elizabeth Hospital

    Hong Kong, Hong Kong, 999077

    Vivian WY Ms. Kwok, +852 34003805, arkers.wong@polyu.edu.hk

    Recruiting

Other trials in Hong Kong

About this study

Official title: Combining Machine Learning and Ecological Momentary Assessment of Depression, Cognitive Function and Daily Activity Behavior to Support Self-Management for Post-stroke Patients: A Feasibility Study

The goal of this feasibility study is to test whether a new approach that combines real-time symptom tracking (Ecological Momentary Assessment) with machine learning can help people recovering from a stroke to better manage depression, thinking difficulties, and daily functioning. The main questions it aims to answer are:

Is this combined approach practical and acceptable for post-stroke survivors? Does the program improve mood, cognitive function, or functional ability to carry out daily activities?

Read more

Participants will:

Use a smartphone app called RehabCare Companion for a period of time Answer brief daily surveys about their mood, thoughts, and activities for one week Receive personalized self-care suggestions generated by machine learning based on their responses Complete assessments of depression, cognition, and functioning before and after the program Take part in a group interview to share their experiences

Conditions
Stroke, Post Stroke
Being tested
Ecological Momentary Assessment based Self-management Program
Keywords
Stroke, Self-management, Depression, Cognitive Function, Ecological Momentary Assessment
Medical subject headings
Stroke, Depression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ecological Momentary Assessment based Self-management ProgramBehavioural

    The research team collects participants' EMA data (ie., depression, cognitive function, daily activity, and contextual data) from participants for 7-day and analyze the data by machine learning in the first phase, while provide real-time, individualized, self-care messages to the participants via a personalized self-care AI app in the second phase.

Study groups in NCT07691411
Study groupRoleWhat they receive
Ecological Momentary Assessment based Self-management ProgramExperimentalEcological Momentary Assessment based Self-management Program
Receives: Behavioral: Ecological Momentary Assessment based Self-management Program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feasibility of the study: acceptance

    The acceptance of participants to the program will be measured by recruitment rate, attrition rate, and retention rate.

    Measured: Immediately after the intervention (T2).

  2. Feasibility of the study: adherence

    The adherence of the participants will be evaluated by using the percentage of completed EMA assessments and the frequency of app usage.

    Measured: Immediately after the intervention (T2).

  3. Feasibility of the study: experience of the participants in using the app

    Participants' experience will be assessed through individual interviews.

    Measured: Immediately after the intervention (T2).

Secondary outcomes (3)
  1. Preliminary effectiveness: depression Levels

    Beck Depression Inventory (BDI) will be used to assess the depression levels of post-stroke patients.

    Measured: Pre-intervention (T1) and immediately after the intervention (T2).

  2. Preliminary effectiveness: cognitive function

    Cognitive function will be screened using Montreal Cognitive Assessment Hong Kong version (HK-MoCA).

    Measured: Pre-intervention (T1) and immediately after the intervention (T2).

  3. Preliminary effectiveness: disability and functioning

    The World Health Organization Disability Assessment Schedule (WHODAS 2.0) is a widely used instrument for assessing disability and functioning in individuals.

    Measured: Pre-intervention (T1) and immediately after the intervention (T2).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Jul 2026
  2. Study start6 Jan 2026
  3. Primary completion30 Sep 2026 (estimated)
  4. Study completion30 Nov 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Model description
Ecological Momentary Assessment based Self-Management Program
Masking
None (open label)
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07691411
Sponsor's protocol ID
WZ8L
Status last verified
Jun 2026
First submitted
29 Jun 2026
Last updated
8 Jul 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Ecological Momentary Assessment based Self-management Program in people with Stroke and Post Stroke, run by The Hong Kong Polytechnic University at 1 site in Hong Kong.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 8 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Arkers KC Prof. Wong, PhD (+852 34003805, arkers.wong@polyu.edu.hk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feasibility of the study: acceptance (time frame: Immediately after the intervention (T2).). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jul 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in